세계의 재조합 세포 배양 보충제 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Recombinant Cell Culture Supplements Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

US $ 4,995 ￦ 6,876,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,043,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,695,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research의 재조합 세포 배양 보충제 시장 보고서는 2024년부터 2032년까지 시장 역학, 성장 요인, 과제 및 새로운 동향에 대한 자세한 개요를 제공합니다. 재조합 세포 배양 보충제 시장의 현재 상황과 미래 전망에 대한 통찰력을 제공합니다.

세계 재조합 세포 배양 보충제 시장은 2024년 5억 2,000만 달러에서 2032년 9억 4,770만 달러에 이르고, 연평균 6% 성장할 것으로 예상됩니다.

주요 인사이트

• 추정 시장 규모(2024년) : 5억 2,000만 달러
• 예상 시장 규모(2032년) : 9억 4,770만 달러
• 세계 시장 성장률(2024-2032년 CAGR) : 6.0%

재조합 세포 배양 보충제 시장 - 조사 범위:

재조합 세포 배양 보충제는 생명공학 및 제약 연구와 생산에서 세포 배양 조건을 개선하기 위해 사용되는 생명공학 제품입니다. 이러한 보충제는 백신, 항체 및 기타 치료용 단백질과 같은 생물학적 제제 생산에 필수적인 세포의 성장과 생산성을 촉진하는 필수 영양소와 성장 인자를 제공합니다. 이 보고서는 세포 배양 기술의 급속한 발전과 바이오 의약품에 대한 수요 증가 등 시장 수요를 촉진하는 주요 요인을 다루고 있습니다.

시장 성장의 촉진요인

바이오의약품 시장 성장과 치료 및 진단용 고품질 유전자 재조합 단백질에 대한 수요 증가가 시장 성장을 견인하고 있습니다. 또한, 윤리, 안전성 및 일관성에 대한 우려로 인해 동물성 보충제에서 유전자 재조합 보충제로의 전환도 시장 성장에 크게 기여하고 있습니다. 또한, 유전공학 및 단백질 발현의 기술적 발전으로 인해 이러한 보충제의 효율성과 효과가 향상되고 있습니다.

시장 성장 억제요인

그러나 유전자 재조합 보충제는 높은 비용과 복잡한 제조 과정 등의 문제에 직면해 있습니다. 또한, 새로운 보충제 승인과 관련된 규제적 장애물도 시장 성장을 저해할 수 있습니다.

시장 기회

세포 배양 성능 향상과 수율 개선을 위한 혁신적인 재조합 보충제 개발에는 큰 기회가 존재합니다. 신흥 시장은 현지 생명공학 산업의 확장과 함께 큰 성장 잠재력을 가지고 있습니다. 또한, 생명과학 분야의 연구개발 활동에 대한 투자가 증가하고 있는 것도 시장 확대의 기회를 제공합니다.

본 보고서에서 다룬 주요 질문들

• 2024년부터 2032년까지 재조합 세포 배양 보충제 시장의 예상 CAGR은?
• 재조합 세포 배양 보충제 시장의 성장을 가속하는 주요 요인은?
• 시장 성장을 저해하는 주요 과제는?
• 재조합 세포 배양 보충제 세계 시장의 주요 기업은?
• 재조합 세포 배양 보충제 시장에서 경쟁력을 유지하기 위해 주요 기업들은 어떤 전략을 채택하고 있는가?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함·제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 중요 성공 요인

• 제품 채택 분석
• 제조업체의 주요 프로모션 전략
• 밸류체인 분석
• 규제 상황
• 제품 USP 분석
• PESTEL 분석
• Porter의 Five Forces 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 용도별
  • 유래별
  • 최종사용자별
  • 국가별
• 2022년 시장 시나리오

제7장 세계의 재조합 세포 배양 보충제 시장 수요(금액) 분석

• 과거 시장 매출(금액) 분석, 2019-2023년
• 현재 및 향후 시장(금액) 예측, 2024-2032년

제8장 세계의 재조합 세포 배양 보충제 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
  • 재조합 성장인자
    • 트랜스포밍 성장인자
    • 표피 성장인자
    • 혈소판 유래 성장인자
    • 섬유아세포 증식 인자
    • 혈관내피세포 성장인자(VEGF)
    • 인터류킨
    • 재조합 줄기세포 인자
    • 기타 성장 인자
  • Recombinant Insulin
  • Recombinant Albumin
  • Recombinant Transferrin
  • Recombinant Trypsin
  • Recombinant Aprotinin
  • Recombinant Lysozyme
  • 기타
• 시장의 매력 분석

제9장 세계의 재조합 세포 배양 보충제 시장 분석 : 용도별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
  • 줄기세포 요법
  • 유전자 치료
  • 바이오프로세스 용도
  • 백신 개발
  • 기타
• 시장의 매력 분석

제10장 세계의 재조합 세포 배양 보충제 시장 분석 : 유래별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
  • 동물
  • 미생물
  • 인간
• 시장의 매력 분석

제11장 세계의 재조합 세포 배양 보충제 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모(미국) 분석, 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모(미국) 분석과 예측, 최종사용자별, 2024-2032년
  • 학술연구기관
  • 바이오의약품 기업
  • 암 연구센터
  • 계약 연구센터(CRO)
• 시장의 매력 분석

제12장 세계의 재조합 세포 배양 보충제 시장 분석 : 지역별

• 서론
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장의 매력 분석

제13장 북미의 재조합 세포 배양 보충제 시장 분석

제14장 라틴아메리카의 재조합 세포 배양 보충제 시장 분석제15장 유럽의 재조합 세포 배양 보충제 시장 분석제16장 동아시아의 재조합 세포 배양 보충제 시장 분석제17장 남아시아의 재조합 세포 배양 보충제 시장 분석제18장 오세아니아 재조합 세포 배양 보충제 시장

제19장 중동 및 아프리카(MEA)의 재조합 세포 배양 보충제 시장 분석

제20장 시장 구조 분석

• 기업 Tier별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 집중
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 상세
  • Merck KGaA
  • Thermo Fisher Scientific
  • Lonza Group AG
  • F. Hoffmann-La Roche
  • Abcam PLC.
  • Hi-Media Laboratories
  • Becton, Dickinson and Company
  • STEMCELL Technologies Inc.
  • Fujifilm Corporation
  • InVitria
  • Biocon
  • Cell Sciences, Inc.

제22장 사용된 전제조건과 두자어

제23장 조사 방법

LSH

영문 목차

영문목차

The Recombinant Cell Culture Supplements Market report by Persistence Market Research provides a detailed overview of market dynamics, growth factors, challenges, and emerging trends from 2024 to 2032. This report offers insights into the current state and future prospects of the Recombinant Cell Culture Supplements Market.

The global recombinant cell culture supplements market is expected to grow at a compound annual growth rate (CAGR) of 6% from USD 520 million in 2024 to USD 947.7 million by 2032.

Key Insights:

• Estimated Market Size (2024): USD 520 Million
• Projected Market Size (2032): USD 947.7 Million
• Global Market Growth Rate (CAGR 2024 to 2032): 6.0%

Recombinant Cell Culture Supplements Market - Report Scope:

Recombinant cell culture supplements are bioengineered products used to enhance cell culture conditions in biotechnological and pharmaceutical research and production. These supplements provide essential nutrients and growth factors that promote cell growth and productivity, critical for producing biologics such as vaccines, antibodies, and other therapeutic proteins. The report highlights the main drivers behind the market demand, including the rapid advancements in cell culture technology and the increasing demand for biopharmaceuticals.

Market Growth Drivers:

The market is driven by the expanding biopharmaceutical industry and the rising demand for high-quality recombinant proteins for therapeutic and diagnostic purposes. The shift from animal-derived supplements to recombinant supplements due to ethical, safety, and consistency concerns also significantly contributes to market growth. Furthermore, technological advancements in genetic engineering and protein expression have enhanced the efficiency and effectiveness of these supplements.

Market Restraints:

However, the market faces challenges such as the high cost of recombinant supplements and the complexity involved in their production. Regulatory hurdles associated with the approval of novel supplements can also impede market growth.

Market Opportunities:

Significant opportunities exist in developing innovative recombinant supplements that can provide enhanced cell culture performance and yield improvements. Emerging markets offer substantial growth potential as local biotech industries expand. Additionally, the increasing investment in research and development activities in the life sciences sector provides opportunities for market expansion.

Key Questions Addressed in the Report:

• What is the Expected CAGR of the Recombinant Cell Culture Supplements Market from 2024 to 2032?
• What are the Key Factors Driving the Growth of the Recombinant Cell Culture Supplements Market?
• What are the Major Challenges that Could Impede the Growth of the Market?
• Who are the Key Players in the Global Recombinant Cell Culture Supplements Market?
• What Strategies are Adopted by Leading Companies to Stay Competitive in the Recombinant Cell Culture Supplements Market?

Competitive Landscape and Business Strategies:

Key players in the Recombinant Cell Culture Supplements Market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Sigma-Aldrich (now part of Merck). These companies focus on innovation, strategic partnerships, and expanding their product portfolios to enhance their market presence. For example, Thermo Fisher Scientific offers a wide range of recombinant supplements designed to optimize cell culture processes and improve product yields.

Key Companies Profiled

• Merck, KGaA
• Thermo Fisher Scientific
• Lonza Group AG
• F. Hoffmann-La Roche
• Abcam PLC.
• Hi-Media Laboratories
• Becton, Dickinson and Company
• STEMCELL Technologies Inc.
• Fujifilm Corporation
• InVitria
• Biocon
• Cell Sciences, Inc.

Segments of Recombinant Cell Culture Supplements Industry Research

By Product:

• Recombinant Growth Factors
• Recombinant Insulin
• Recombinant Albumin
• Recombinant Transferrin
• Recombinant Trypsin
• Recombinant Aprotinin
• Recombinant Lysozyme
• Others

By Application:

• Stem Cell Therapy
• Gene Therapy
• Bioprocess Application
• Vaccine Development
• Others

By Source:

• Animals
• Microorganisms
• Human

By End User:

• Academic and Research Institutes
• Biopharmaceutical Companies
• Cancer Research Centers
• Contract Research Centers (CROs)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Promotional Strategies by Manufacturers
• 4.3. Value Chain Analysis
• 4.4. Regulatory Landscape
• 4.5. Product USP Analysis
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Cell Culture Media Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increasing Focus on Oncological Research
  • 5.2.2. Growing Demand for Growth Factors
  • 5.2.3. Rising Need of Cytokines in the Stem Cell Biology
  • 5.2.4. Increasing Demand for Growth Factor in Regenerative Medicine
  • 5.2.5. Growing Manufacturers Investments
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Application
  • 6.1.3. By Source
  • 6.1.4. By End User
  • 6.1.5. By Country
• 6.2. 2022 Market Scenario

7. Global Recombinant Cell Culture Supplements Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2024-2032
  • 8.3.1. Recombinant Growth Factors
    • 8.3.1.1. Transforming Growth Factor
    • 8.3.1.2. Epidermal Growth Factor
    • 8.3.1.3. Platelet-Derived Growth Factors
    • 8.3.1.4. Fibroblast Growth Factor
    • 8.3.1.5. Vascular Endothelial Growth Factors (VEGFs)
    • 8.3.1.6. Interleukins
    • 8.3.1.7. Recombinant Stem Cell Factor
    • 8.3.1.8. Other Growth Factors
  • 8.3.2. Recombinant Insulin
  • 8.3.3. Recombinant Albumin
  • 8.3.4. Recombinant Transferrin
  • 8.3.5. Recombinant Trypsin
  • 8.3.6. Recombinant Aprotinin
  • 8.3.7. Recombinant Lysozyme
  • 8.3.8. Others
• 8.4. Market Attractiveness Analysis, by Product

9. Global Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032, By Application

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Application, 2024-2032
  • 9.3.1. Stem Cell Therapy
  • 9.3.2. Gene Therapy
  • 9.3.3. Bioprocess Application
  • 9.3.4. Vaccine Development
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis, by Application

10. Global Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032, By Source

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis, By Source, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Source, 2024-2032
  • 10.3.1. Animals
  • 10.3.2. Microorganisms
  • 10.3.3. Human
• 10.4. Market Attractiveness Analysis, by Source

11. Global Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2024-2032
  • 11.3.1. Academic and Research Institutes
  • 11.3.2. Biopharmaceutical Companies
  • 11.3.3. Cancer Research Centers
  • 11.3.4. Contract Research Centers (CROs)
• 11.4. Market Attractiveness Analysis, by End User

12. Global Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
• 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Region, 2024-2032
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis, by Region

13. North America Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product
  • 13.3.3. By Application
  • 13.3.4. By Source
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Application
  • 13.4.4. By Source
  • 13.4.5. By End User
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Country Level Analysis & Forecast
  • 13.7.1. U.S. Recombinant Cell Culture Supplements Market Analysis
    • 13.7.1.1. Introduction
    • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.7.1.2.1. By Product
      • 13.7.1.2.2. By Application
      • 13.7.1.2.3. By Source
      • 13.7.1.2.4. By End User
  • 13.7.2. Canada Recombinant Cell Culture Supplements Market Analysis
    • 13.7.2.1. Introduction
    • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.7.2.2.1. By Product
      • 13.7.2.2.2. By Application
      • 13.7.2.2.3. By Source
      • 13.7.2.2.4. By End User

14. Latin America Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Product
  • 14.3.3. By Application
  • 14.3.4. By Source
  • 14.3.5. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Application
  • 14.4.4. By Source
  • 14.4.5. By End User
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Country Level Analysis & Forecast
  • 14.7.1. Mexico Recombinant Cell Culture Supplements Market Analysis
    • 14.7.1.1. Introduction
    • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.1.2.1. By Product
      • 14.7.1.2.2. By Application
      • 14.7.1.2.3. By Source
      • 14.7.1.2.4. By End User
  • 14.7.2. Brazil Recombinant Cell Culture Supplements Market Analysis
    • 14.7.2.1. Introduction
    • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.2.2.1. By Product
      • 14.7.2.2.2. By Application
      • 14.7.2.2.3. By Source
      • 14.7.2.2.4. By End User
  • 14.7.3. Argentina Recombinant Cell Culture Supplements Market Analysis
    • 14.7.3.1. Introduction
    • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.3.2.1. By Product
      • 14.7.3.2.2. By Application
      • 14.7.3.2.3. By Source
      • 14.7.3.2.4. By End User

15. Europe Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Product
  • 15.3.3. By Application
  • 15.3.4. By Source
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Application
  • 15.4.4. By Source
  • 15.4.5. By End User
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Country Level Analysis & Forecast
  • 15.7.1. Germany Recombinant Cell Culture Supplements Market Analysis
    • 15.7.1.1. Introduction
    • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.1.2.1. By Product
      • 15.7.1.2.2. By Application
      • 15.7.1.2.3. By Source
      • 15.7.1.2.4. By End User
  • 15.7.2. Italy Recombinant Cell Culture Supplements Market Analysis
    • 15.7.2.1. Introduction
    • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.2.2.1. By Product
      • 15.7.2.2.2. By Application
      • 15.7.2.2.3. By Source
      • 15.7.2.2.4. By End User
  • 15.7.3. France Recombinant Cell Culture Supplements Market Analysis
    • 15.7.3.1. Introduction
    • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.3.2.1. By Product
      • 15.7.3.2.2. By Application
      • 15.7.3.2.3. By Source
      • 15.7.3.2.4. By End User
  • 15.7.4. U.K. Recombinant Cell Culture Supplements Market Analysis
    • 15.7.4.1. Introduction
    • 15.7.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.4.2.1. By Product
      • 15.7.4.2.2. By Application
      • 15.7.4.2.3. By Source
      • 15.7.4.2.4. By End User
  • 15.7.5. Spain Recombinant Cell Culture Supplements Market Analysis
    • 15.7.5.1. Introduction
    • 15.7.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.5.2.1. By Product
      • 15.7.5.2.2. By Application
      • 15.7.5.2.3. By Source
      • 15.7.5.2.4. By End User
  • 15.7.6. BENELUX Recombinant Cell Culture Supplements Market Analysis
    • 15.7.6.1. Introduction
    • 15.7.6.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.6.2.1. By Product
      • 15.7.6.2.2. By Application
      • 15.7.6.2.3. By Source
      • 15.7.6.2.4. By End User
  • 15.7.7. Russia Recombinant Cell Culture Supplements Market Analysis
    • 15.7.7.1. Introduction
    • 15.7.7.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.7.2.1. By Product
      • 15.7.7.2.2. By Application
      • 15.7.7.2.3. By Source
      • 15.7.7.2.4. By End User

16. East Asia Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032

• 16.1. Introduction
• 16.2. Historical Market End User (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Product
  • 16.3.3. By Application
  • 16.3.4. By Source
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Product
  • 16.4.2. By Application
  • 16.4.3. By Source
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Country Level Analysis & Forecast
  • 16.7.1. China Recombinant Cell Culture Supplements Market Analysis
    • 16.7.1.1. Introduction
    • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.1.2.1. By Product
      • 16.7.1.2.2. By Application
      • 16.7.1.2.3. By Source
      • 16.7.1.2.4. By End User
  • 16.7.2. Japan Recombinant Cell Culture Supplements Market Analysis
    • 16.7.2.1. Introduction
    • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.2.2.1. By Product
      • 16.7.2.2.2. By Application
      • 16.7.2.2.3. By Source
      • 16.7.2.2.4. By End User
  • 16.7.3. South Korea Recombinant Cell Culture Supplements Market Analysis
    • 16.7.3.1. Introduction
    • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.3.2.1. By Product
      • 16.7.3.2.2. By Application
      • 16.7.3.2.3. By Source
      • 16.7.3.2.4. By End User

17. South Asia Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By Application
  • 17.3.4. By Source
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Application
  • 17.4.4. By Source
  • 17.4.5. By End User
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Country Level Analysis & Forecast
  • 17.7.1. India Recombinant Cell Culture Supplements Market Analysis
    • 17.7.1.1. Introduction
    • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.7.1.2.1. By Product
      • 17.7.1.2.2. By Application
      • 17.7.1.2.3. By Source
      • 17.7.1.2.4. By End User
  • 17.7.2. Indonesia Recombinant Cell Culture Supplements Market Analysis
    • 17.7.2.1. Introduction
    • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.7.2.2.1. By Product
      • 17.7.2.2.2. By Application
      • 17.7.2.2.3. By Source
      • 17.7.2.2.4. By End User
  • 17.7.3. Malaysia Recombinant Cell Culture Supplements Market Analysis
    • 17.7.3.1. Introduction
    • 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.7.3.2.1. By Product
      • 17.7.3.2.2. By Application
      • 17.7.3.2.3. By Source
      • 17.7.3.2.4. By End User
  • 17.7.4. Thailand Recombinant Cell Culture Supplements Market Analysis
    • 17.7.4.1. Introduction
    • 17.7.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.7.4.2.1. By Product
      • 17.7.4.2.2. By Application
      • 17.7.4.2.3. By Source
      • 17.7.4.2.4. By End User

18. Oceania Recombinant Cell Culture Supplements Market 2014-2022 and Forecast 2024-2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product
  • 18.3.3. By Application
  • 18.3.4. By Source
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Application
  • 18.4.4. By Source
  • 18.4.5. By End User
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Country Level Analysis & Forecast
  • 18.7.1. Australia Recombinant Cell Culture Supplements Market Analysis
    • 18.7.1.1. Introduction
    • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.7.1.2.1. By Product
      • 18.7.1.2.2. By Application
      • 18.7.1.2.3. By Source
      • 18.7.1.2.4. By End User
  • 18.7.2. New Zealand Recombinant Cell Culture Supplements Market Analysis
    • 18.7.2.1. Introduction
    • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.7.2.2.1. By Product
      • 18.7.2.2.2. By Application
      • 18.7.2.2.3. By Source
      • 18.7.2.2.4. By End User

19. Middle East and Africa (MEA) Recombinant Cell Culture Supplements Market Analysis 2019-2023 and Forecast 2024-2032

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis, by Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2024-2032
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkey
    • 19.3.1.3. South Africa
    • 19.3.1.4. North Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Product
  • 19.3.3. By Application
  • 19.3.4. By Source
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Product
  • 19.4.2. By Application
  • 19.4.3. By Source
  • 19.4.4. By End User
• 19.5. Market Trends
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Country Level Analysis & Forecast
  • 19.7.1. GCC Countries Recombinant Cell Culture Supplements Market Analysis
    • 19.7.1.1. Introduction
    • 19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.7.1.2.1. By Product
      • 19.7.1.2.2. By Application
      • 19.7.1.2.3. By Source
      • 19.7.1.2.4. By End User
  • 19.7.2. Turkey Recombinant Cell Culture Supplements Market Analysis
    • 19.7.2.1. Introduction
    • 19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.7.2.2.1. By Product
      • 19.7.2.2.2. By Application
      • 19.7.2.2.3. By Source
      • 19.7.2.2.4. By End User
  • 19.7.3. South Africa Recombinant Cell Culture Supplements Market Analysis
    • 19.7.3.1. Introduction
    • 19.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.7.3.2.1. By Product
      • 19.7.3.2.2. By Application
      • 19.7.3.2.3. By Source
      • 19.7.3.2.4. By End User
  • 19.7.4. North Africa Recombinant Cell Culture Supplements Market Analysis
    • 19.7.4.1. Introduction
    • 19.7.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.7.4.2.1. By Product
      • 19.7.4.2.2. By Application
      • 19.7.4.2.3. By Source
      • 19.7.4.2.4. By End User

20. Market Structure Analysis

• 20.1. Market Analysis, by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Concentration
• 20.4. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Deep Dive
  • 21.2.1. Merck KGaA
    • 21.2.1.1. Overview
    • 21.2.1.2. Product Portfolio
    • 21.2.1.3. Sales Footprint
    • 21.2.1.4. Key Financials
    • 21.2.1.5. SWOT Analysis
    • 21.2.1.6. Strategy Overview
      • 21.2.1.6.1. Marketing Strategy
      • 21.2.1.6.2. Product Strategy
      • 21.2.1.6.3. Channel Strategy
  • 21.2.2. Thermo Fisher Scientific
    • 21.2.2.1. Overview
    • 21.2.2.2. Product Portfolio
    • 21.2.2.3. Sales Footprint
    • 21.2.2.4. Key Financials
    • 21.2.2.5. SWOT Analysis
    • 21.2.2.6. Strategy Overview
      • 21.2.2.6.1. Marketing Strategy
      • 21.2.2.6.2. Product Strategy
      • 21.2.2.6.3. Channel Strategy
  • 21.2.3. Lonza Group AG
    • 21.2.3.1. Overview
    • 21.2.3.2. Product Portfolio
    • 21.2.3.3. Sales Footprint
    • 21.2.3.4. Key Financials
    • 21.2.3.5. SWOT Analysis
    • 21.2.3.6. Strategy Overview
      • 21.2.3.6.1. Marketing Strategy
      • 21.2.3.6.2. Product Strategy
      • 21.2.3.6.3. Channel Strategy
  • 21.2.4. F. Hoffmann-La Roche
    • 21.2.4.1. Overview
    • 21.2.4.2. Product Portfolio
    • 21.2.4.3. Sales Footprint
    • 21.2.4.4. Key Financials
    • 21.2.4.5. SWOT Analysis
    • 21.2.4.6. Strategy Overview
      • 21.2.4.6.1. Marketing Strategy
      • 21.2.4.6.2. Product Strategy
      • 21.2.4.6.3. Channel Strategy
  • 21.2.5. Abcam PLC.
    • 21.2.5.1. Overview
    • 21.2.5.2. Product Portfolio
    • 21.2.5.3. Sales Footprint
    • 21.2.5.4. Key Financials
    • 21.2.5.5. SWOT Analysis
    • 21.2.5.6. Strategy Overview
      • 21.2.5.6.1. Marketing Strategy
      • 21.2.5.6.2. Product Strategy
      • 21.2.5.6.3. Channel Strategy
  • 21.2.6. Hi-Media Laboratories
    • 21.2.6.1. Overview
    • 21.2.6.2. Product Portfolio
    • 21.2.6.3. Sales Footprint
    • 21.2.6.4. Key Financials
    • 21.2.6.5. SWOT Analysis
    • 21.2.6.6. Strategy Overview
      • 21.2.6.6.1. Marketing Strategy
      • 21.2.6.6.2. Product Strategy
      • 21.2.6.6.3. Channel Strategy
  • 21.2.7. Becton, Dickinson and Company
    • 21.2.7.1. Overview
    • 21.2.7.2. Product Portfolio
    • 21.2.7.3. Sales Footprint
    • 21.2.7.4. Key Financials
    • 21.2.7.5. SWOT Analysis
    • 21.2.7.6. Strategy Overview
      • 21.2.7.6.1. Marketing Strategy
      • 21.2.7.6.2. Product Strategy
      • 21.2.7.6.3. Channel Strategy
  • 21.2.8. STEMCELL Technologies Inc.
    • 21.2.8.1. Overview
    • 21.2.8.2. Product Portfolio
    • 21.2.8.3. Sales Footprint
    • 21.2.8.4. Key Financials
    • 21.2.8.5. SWOT Analysis
    • 21.2.8.6. Strategy Overview
      • 21.2.8.6.1. Marketing Strategy
      • 21.2.8.6.2. Product Strategy
      • 21.2.8.6.3. Channel Strategy
  • 21.2.9. Fujifilm Corporation
    • 21.2.9.1. Overview
    • 21.2.9.2. Product Portfolio
    • 21.2.9.3. Sales Footprint
    • 21.2.9.4. Key Financials
    • 21.2.9.5. SWOT Analysis
    • 21.2.9.6. Strategy Overview
      • 21.2.9.6.1. Marketing Strategy
      • 21.2.9.6.2. Product Strategy
      • 21.2.9.6.3. Channel Strategy
  • 21.2.10. InVitria
    • 21.2.10.1. Overview
    • 21.2.10.2. Product Portfolio
    • 21.2.10.3. Sales Footprint
    • 21.2.10.4. Key Financials
    • 21.2.10.5. SWOT Analysis
    • 21.2.10.6. Strategy Overview
      • 21.2.10.6.1. Marketing Strategy
      • 21.2.10.6.2. Product Strategy
      • 21.2.10.6.3. Channel Strategy
  • 21.2.11. Biocon
    • 21.2.11.1. Overview
    • 21.2.11.2. Product Portfolio
    • 21.2.11.3. Sales Footprint
    • 21.2.11.4. Key Financials
    • 21.2.11.5. SWOT Analysis
    • 21.2.11.6. Strategy Overview
      • 21.2.11.6.1. Marketing Strategy
      • 21.2.11.6.2. Product Strategy
      • 21.2.11.6.3. Channel Strategy
  • 21.2.12. Cell Sciences, Inc.
    • 21.2.12.1. Overview
    • 21.2.12.2. Product Portfolio
    • 21.2.12.3. Sales Footprint
    • 21.2.12.4. Key Financials
    • 21.2.12.5. SWOT Analysis
    • 21.2.12.6. Strategy Overview
      • 21.2.12.6.1. Marketing Strategy
      • 21.2.12.6.2. Product Strategy
      • 21.2.12.6.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료